DE69828624D1 - Biologisch aktive verbindungen enthaltende multilamellare koaleszenzvesikel (mlcv) - Google Patents
Biologisch aktive verbindungen enthaltende multilamellare koaleszenzvesikel (mlcv)Info
- Publication number
- DE69828624D1 DE69828624D1 DE69828624T DE69828624T DE69828624D1 DE 69828624 D1 DE69828624 D1 DE 69828624D1 DE 69828624 T DE69828624 T DE 69828624T DE 69828624 T DE69828624 T DE 69828624T DE 69828624 D1 DE69828624 D1 DE 69828624D1
- Authority
- DE
- Germany
- Prior art keywords
- biologically active
- vesicles
- active compound
- mlcvs
- multilamellar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
- A61K9/1278—Post-loading, e.g. by ion or pH gradient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
- Y10S977/907—Liposome
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6060697P | 1997-10-01 | 1997-10-01 | |
US60606P | 1997-10-01 | ||
PCT/US1998/020780 WO1999016426A2 (en) | 1997-10-01 | 1998-10-01 | Multilamellar coalescence vesicles (mlcv) containing biologically active compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69828624D1 true DE69828624D1 (de) | 2005-02-17 |
DE69828624T2 DE69828624T2 (de) | 2005-12-22 |
Family
ID=22030591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69828624T Expired - Lifetime DE69828624T2 (de) | 1997-10-01 | 1998-10-01 | Biologisch aktive verbindungen enthaltende multilamellare koaleszenzvesikel (mlcv) |
Country Status (9)
Country | Link |
---|---|
US (1) | US6544549B1 (de) |
EP (1) | EP1019026B1 (de) |
JP (1) | JP2001517693A (de) |
AT (1) | ATE286717T1 (de) |
AU (1) | AU745000B2 (de) |
CA (1) | CA2305533C (de) |
DE (1) | DE69828624T2 (de) |
IN (1) | IN190388B (de) |
WO (1) | WO1999016426A2 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2006095798A1 (ja) * | 2005-03-09 | 2008-08-14 | サンスター株式会社 | フィトステロールを含んだリポソームを含有する抗癌用経口組成物、該リポソームによる癌の予防又は治療 |
US7662405B2 (en) * | 2005-08-09 | 2010-02-16 | The Research Foundation Of State University Of New York | Compositions and methods of preparation of liposomal microparticulate IL-12 |
WO2008005045A2 (en) | 2005-12-30 | 2008-01-10 | Dermazone Solutions, Inc. | Nanolipidic particles |
US20140271782A1 (en) | 2013-03-15 | 2014-09-18 | Dermazone Solutions, Inc. | Method for preparing nanolipids with encapsulated alcohol |
US9283184B2 (en) | 2008-11-24 | 2016-03-15 | Massachusetts Institute Of Technology | Methods and compositions for localized agent delivery |
US20100324124A1 (en) * | 2009-06-17 | 2010-12-23 | Massachusetts Institute Of Technology | Compositions and methods relating to DNA-based particles |
US20100323018A1 (en) * | 2009-06-17 | 2010-12-23 | Massachusetts Institute Of Technology | Branched DNA/RNA monomers and uses thereof |
KR101783068B1 (ko) * | 2010-03-19 | 2017-09-28 | 메사추세츠 인스티튜트 오브 테크놀로지 | 지질 소포 조성물 및 사용 방법 |
US9149432B2 (en) | 2010-03-19 | 2015-10-06 | Massachusetts Institute Of Technology | Lipid vesicle compositions and methods of use |
US20110229556A1 (en) * | 2010-03-19 | 2011-09-22 | Massachusetts Institute Of Technology | Lipid-coated polymer particles for immune stimulation |
CN102654505A (zh) * | 2012-05-16 | 2012-09-05 | 江苏省原子医学研究所 | 一种检测il-2-hsa的时间分辨荧光免疫分析试剂盒及其检测方法 |
EP2925297B1 (de) * | 2012-11-02 | 2017-06-21 | CyTuVax | Zusammensetzung enthaltend zytokin makroaggregate |
US9770415B2 (en) * | 2012-11-27 | 2017-09-26 | Southwest Research Institute | Delivery substrates from aligned polymer biomaterials for tissue repair |
ES2904276T3 (es) | 2013-09-27 | 2022-04-04 | Massachusetts Inst Technology | Nanoestructuras de proteínas biológicamente activas sin vehículo |
AU2016256979B2 (en) | 2015-05-04 | 2021-01-28 | Versantis AG | Method for preparing transmembrane pH-gradient vesicles |
EP3334417A4 (de) | 2015-08-12 | 2019-07-17 | Massachusetts Institute of Technology | Zelloberflächenkopplung von nanopartikeln |
AU2017283480A1 (en) | 2016-06-13 | 2019-01-24 | Torque Therapeutics, Inc. | Methods and compositions for promoting immune cell function |
EP3678701A4 (de) | 2017-09-05 | 2021-12-01 | Torque Therapeutics, Inc. | Therapeutische proteinzusammensetzungen und verfahren zur herstellung und verwendung davon |
US20200078316A1 (en) | 2018-09-06 | 2020-03-12 | NuVessl, Inc. | Method of Using Cannabinoids Encapsulated in Phospholipid Carriers for Transmucosal and Transdermal Administration |
US20200188301A1 (en) | 2018-12-14 | 2020-06-18 | NuVessl, Inc. | Method for Enhancing Passenger Molecule Loading |
US20230096704A1 (en) * | 2020-02-05 | 2023-03-30 | University Of Florida Research Foundation, Incorporated | Rna-loaded nanoparticles and use thereof for the treatment of cancer |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04356421A (ja) | 1991-03-06 | 1992-12-10 | Green Cross Corp:The | プロスタグランジン類含有脂肪小体組成物 |
US6312718B1 (en) | 1996-02-16 | 2001-11-06 | Biomira Usa, Inc. | Vaccine for B-cell malignancies |
-
1998
- 1998-01-01 IN IN2930DE1998 patent/IN190388B/en unknown
- 1998-10-01 EP EP98950869A patent/EP1019026B1/de not_active Expired - Lifetime
- 1998-10-01 AU AU96800/98A patent/AU745000B2/en not_active Ceased
- 1998-10-01 AT AT98950869T patent/ATE286717T1/de not_active IP Right Cessation
- 1998-10-01 WO PCT/US1998/020780 patent/WO1999016426A2/en active IP Right Grant
- 1998-10-01 CA CA002305533A patent/CA2305533C/en not_active Expired - Fee Related
- 1998-10-01 US US09/164,350 patent/US6544549B1/en not_active Expired - Lifetime
- 1998-10-01 JP JP2000513564A patent/JP2001517693A/ja active Pending
- 1998-10-01 DE DE69828624T patent/DE69828624T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69828624T2 (de) | 2005-12-22 |
WO1999016426A2 (en) | 1999-04-08 |
EP1019026B1 (de) | 2005-01-12 |
CA2305533A1 (en) | 1999-04-08 |
AU9680098A (en) | 1999-04-23 |
ATE286717T1 (de) | 2005-01-15 |
WO1999016426A3 (en) | 1999-06-17 |
US6544549B1 (en) | 2003-04-08 |
EP1019026A2 (de) | 2000-07-19 |
AU745000B2 (en) | 2002-03-07 |
IN190388B (de) | 2003-07-26 |
CA2305533C (en) | 2009-12-01 |
JP2001517693A (ja) | 2001-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69828624D1 (de) | Biologisch aktive verbindungen enthaltende multilamellare koaleszenzvesikel (mlcv) | |
ATE341310T1 (de) | Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome | |
NO20013862D0 (no) | Fremgangsmate for a regulere liposomstorrelse | |
DK0580817T3 (da) | Farmaceutisk præparat og fremgangsmåde til fremstilling deraf | |
HUP9802578A3 (en) | Phenylacetic acid derivatives, process and intermediates for producing them, fingicide, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients and use thereof | |
AU8141891A (en) | Unilamellar vesicles | |
ATE228822T1 (de) | Mikroemulsionen zur verwendung als träger zur verabreichung von wirkstoffen | |
ZA200110000B (en) | Novel preparation and administration form comprising an acid-labile active compound. | |
NZ334561A (en) | Preparation of multivesicular liposomes for controPreparation of multivesicular liposomes for controlled release of active agents lled release of active agents | |
DE69614385T2 (de) | Verfahren zur herstellung einer liposomen-zubereitung | |
JP2001517693A5 (de) | ||
NZ503293A (en) | Liposomal camptothecin formulations also comprising at least one phospholipid | |
NO20023139D0 (no) | Liposomer som inneholder en forbindelse i supermettet lösning | |
CA2050679A1 (en) | Preparation of liposome and lipid complex compositions | |
NO970581L (no) | Fremgangsmåte for fremstilling av 4-oksoimidazoliniumsalter | |
KR940703651A (ko) | 리포솜 이트라코나졸 제제[liposomal itraconazole formula-tions] | |
ES2042437T1 (es) | Procedimiento de preparacion de una lipoproteina modificaa por incorporacion de una substancia activa lipofila. | |
HUT64518A (en) | Process for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents | |
EA200201003A1 (ru) | Аморфная модификация торасемида | |
PT97468A (pt) | Processo para a preparacao de suspensoes aquosas de lipossomas contendo em especial derivados iodados ou complexos de gadolinio | |
WO1998055448A3 (de) | Fluoralkencarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende insektizidemittel | |
TR200000154T2 (tr) | 2,4,4-Trisübstitüe-1,3-Dioksolan mantar önleyiciler. | |
De Armas et al. | (25R)-6β-Acetoxy-3β-bromo-5α-spirostan-23-one | |
TH58479B (th) | สารผสมสำหรับใช้ทางปากต้านแบคทีเรียชนิดลิวพูโลนที่ถูกไฮโดรจีเนตและคงตัว | |
ATE212838T1 (de) | Pharmazeutische zubereitungen, enthaltend nifedipin und verfahren zu ihrer herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: BIOMIRA INC., EDMONTON, ALBERTA, CA |
|
8364 | No opposition during term of opposition |